171 related articles for article (PubMed ID: 28542548)
1. Robustness analysis of the detailed kinetic model of an ErbB signaling network by using dynamic sensitivity.
Masunaga H; Sugimoto Y; Magi S; Itasaki R; Okada-Hatakeyama M; Kurata H
PLoS One; 2017; 12(5):e0178250. PubMed ID: 28542548
[TBL] [Abstract][Full Text] [Related]
2. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L
Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713
[TBL] [Abstract][Full Text] [Related]
3. Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses.
Birtwistle MR; Hatakeyama M; Yumoto N; Ogunnaike BA; Hoek JB; Kholodenko BN
Mol Syst Biol; 2007; 3():144. PubMed ID: 18004277
[TBL] [Abstract][Full Text] [Related]
4. Quantitative transcriptional control of ErbB receptor signaling undergoes graded to biphasic response for cell differentiation.
Nagashima T; Shimodaira H; Ide K; Nakakuki T; Tani Y; Takahashi K; Yumoto N; Hatakeyama M
J Biol Chem; 2007 Feb; 282(6):4045-56. PubMed ID: 17142811
[TBL] [Abstract][Full Text] [Related]
5. A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling.
Hatakeyama M; Kimura S; Naka T; Kawasaki T; Yumoto N; Ichikawa M; Kim JH; Saito K; Saeki M; Shirouzu M; Yokoyama S; Konagaya A
Biochem J; 2003 Jul; 373(Pt 2):451-63. PubMed ID: 12691603
[TBL] [Abstract][Full Text] [Related]
6. Essential role for Rac in heregulin beta1 mitogenic signaling: a mechanism that involves epidermal growth factor receptor and is independent of ErbB4.
Yang C; Liu Y; Lemmon MA; Kazanietz MG
Mol Cell Biol; 2006 Feb; 26(3):831-42. PubMed ID: 16428439
[TBL] [Abstract][Full Text] [Related]
7. Matuzumab and cetuximab activate the epidermal growth factor receptor but fail to trigger downstream signaling by Akt or Erk.
Yoshida T; Okamoto I; Okabe T; Iwasa T; Satoh T; Nishio K; Fukuoka M; Nakagawa K
Int J Cancer; 2008 Apr; 122(7):1530-8. PubMed ID: 18033688
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
Motoyama AB; Hynes NE; Lane HA
Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
[TBL] [Abstract][Full Text] [Related]
9. Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells.
Gan Y; Shi C; Inge L; Hibner M; Balducci J; Huang Y
Oncogene; 2010 Sep; 29(35):4947-58. PubMed ID: 20562913
[TBL] [Abstract][Full Text] [Related]
10. Ligand-specific c-Fos expression emerges from the spatiotemporal control of ErbB network dynamics.
Nakakuki T; Birtwistle MR; Saeki Y; Yumoto N; Ide K; Nagashima T; Brusch L; Ogunnaike BA; Okada-Hatakeyama M; Kholodenko BN
Cell; 2010 May; 141(5):884-96. PubMed ID: 20493519
[TBL] [Abstract][Full Text] [Related]
11. Signaling to extracellular signal-regulated kinase from ErbB1 kinase and protein kinase C: feedback, heterogeneity, and gating.
Perrett RM; Fowkes RC; Caunt CJ; Tsaneva-Atanasova K; Bowsher CG; McArdle CA
J Biol Chem; 2013 Jul; 288(29):21001-21014. PubMed ID: 23754287
[TBL] [Abstract][Full Text] [Related]
12. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
Li B; Chang CM; Yuan M; McKenna WG; Shu HK
Cancer Res; 2003 Nov; 63(21):7443-50. PubMed ID: 14612544
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of the PI3-kinase/Akt pathway by ERK MAP kinase in growth factor signaling.
Hayashi H; Tsuchiya Y; Nakayama K; Satoh T; Nishida E
Genes Cells; 2008 Sep; 13(9):941-7. PubMed ID: 18691227
[TBL] [Abstract][Full Text] [Related]
14. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
Pan MH; Lin CC; Lin JK; Chen WJ
J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
[TBL] [Abstract][Full Text] [Related]
15. Akt- and MAPK-mediated activation and secretion of MMP-9 into stroma in breast cancer cells upon heregulin treatment.
Cho SJ; Chae MJ; Shin BK; Kim HK; Kim A
Mol Med Rep; 2008; 1(1):83-8. PubMed ID: 21479382
[TBL] [Abstract][Full Text] [Related]
16. Modeling Cellular Noise Underlying Heterogeneous Cell Responses in the Epidermal Growth Factor Signaling Pathway.
Iwamoto K; Shindo Y; Takahashi K
PLoS Comput Biol; 2016 Nov; 12(11):e1005222. PubMed ID: 27902699
[TBL] [Abstract][Full Text] [Related]
17. EGF-induced cell migration is mediated by ERK and PI3K/AKT pathways in cultured human lens epithelial cells.
Jiang Q; Zhou C; Bi Z; Wan Y
J Ocul Pharmacol Ther; 2006 Apr; 22(2):93-102. PubMed ID: 16722795
[TBL] [Abstract][Full Text] [Related]
18. Gallic acid abolishes the EGFR/Src/Akt/Erk-mediated expression of matrix metalloproteinase-9 in MCF-7 breast cancer cells.
Chen YJ; Lin KN; Jhang LM; Huang CH; Lee YC; Chang LS
Chem Biol Interact; 2016 May; 252():131-40. PubMed ID: 27087131
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 upregulates EGF-stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytes.
Dajani OF; Meisdalen K; Guren TK; Aasrum M; Tveteraas IH; Lilleby P; Thoresen GH; Sandnes D; Christoffersen T
J Cell Physiol; 2008 Feb; 214(2):371-80. PubMed ID: 17654493
[TBL] [Abstract][Full Text] [Related]
20. Both mitogen-activated protein kinase (MAPK)/extracellular-signal-regulated kinases (ERK) 1/2 and phosphatidylinositide-3-OH kinase (PI3K)/Akt pathways regulate activation of E-twenty-six (ETS)-like transcription factor 1 (Elk-1) in U138 glioblastoma cells.
Mut M; Lule S; Demir O; Kurnaz IA; Vural I
Int J Biochem Cell Biol; 2012 Feb; 44(2):302-10. PubMed ID: 22085529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
